BSEBoard Meeting31 Oct 2026 · 31 Oct 2026, 07:03 pm
Cresanto Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve 1. Un-audited Financial Results of the Company for the Second quarter ended 30th September, 2026. 2. To note and take on record the Limited Review Report for the Second quarter ended 30th September, 2026. 3. To consider any other business with the permission of the Chair.
Cresanto Global Ltd · 531207
✦ AI SummaryResults
Cresanto Global Ltd has scheduled a Board Meeting on 05/11/2026 to consider and approve un-audited financial results for the second quarter ended 30/09/2026, and to note the limited review report for the same period.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Cresanto Global Ltd - 531207 - Board Meeting Intimation for Approval Of Q2 Financial Result For 2026-27.
Attachments (1)
📄pdf
Download →
3f6afce8-921b-43cb-9650-54c22f0d842d.pdf
View document text
CP.LSA“!TQ | CRESANTO GLOBAL LIMITED
THE POWER BEHIND (Formerly kiown as Raymed Labs Limited)
Reg.off: C- 273, C block, Sector 63, Gautam Buddha Nagar, Noida,Uttar Pradesh-201301
CIN:L22203UP1992PLC014240 Website: www.cresantoglobal.com Email: paymedlabs@rediffmail.com. Phone no. 7738669898
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai- 400001
Scrip code- 531207
Subject: Intimation of Board Meeting
Ref: Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir/ Madam,
In term of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
it is hereby intimated that the Meeting of Board of Directors of the Company is scheduled to be held
on Thursday, 05*" November, 2026 at the corporate office of the company to inter alia consider and
approve:
1. Un-audited Financial Results of the Company for the second quarter ended 30" September,
2026.
2. To note and take on record the Limited Review Report for the second quarter ended 30"
September, 2026.
3. To consider any other business with the permission of the Chair.
Further, in terms of the Prohibition of Insider Trading Code adopted by the Company the Window
Closure for Trading by Designated Persons of the Company shall remain close from Thursday, 01%
October, 2026 till Saturday, 07" November, 2026, i.e. 48 hours after the declaration of Unaudited
Financial Results of the Company for the quarter ended 30t September, 2026.
Thanking you,
For Cresanto Global Limited
(Formerly known as Raymed Labs Limited)
(Prashant Nathmal Bajaj)
Managing Director
DIN: 06634046
Date: 31° October, 2026
Place: Mumbai